Long-term treatment with dalteparin low-molecular-weight heparin (LMWH) may improve survival in patients with non-metastatic malignancy and venous thromboembolism (VTE) Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Lee, AYY
  • Julian, JA
  • Levine, Mark Norman
  • Baker, RI
  • Bowden, C
  • Kakkar, AK
  • Prins, M
  • Rickles, FR
  • Gent, M

publication date

  • July 2003